Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C.

Estrabaud E, Appourchaux K, Bièche I, Carrat F, Lapalus M, Lada O, Martinot-Peignoux M, Boyer N, Marcellin P, Vidaud M, Asselah T.

PLoS One. 2015 Apr 6;10(4):e0121395. doi: 10.1371/journal.pone.0121395. eCollection 2015.

2.

Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure.

Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trépo C, Kao JH, Carrat F, Lacombe K, Schinazi RF, Barré-Sinoussi F, Delfraissy JF, Zoulim F.

Gut. 2015 Feb 10. pii: gutjnl-2014-308943. doi: 10.1136/gutjnl-2014-308943. [Epub ahead of print] Review.

PMID:
25670809
3.

Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.

Bailly F, Virlogeux V, Dufour C, Pradat P, Hézode C, Larrey D, Alric L, Samuel D, Bourlière M, Métivier S, Zarski JP, Fontaine H, Loustaud-Ratti V, Serfaty L, Bronowicki JP, Carrat F, Zoulim F; CUPIC Study Group.

Clin Res Hepatol Gastroenterol. 2015 Jan 27. pii: S2210-7401(15)00002-9. doi: 10.1016/j.clinre.2014.12.007. [Epub ahead of print]

PMID:
25636238
4.

Multiplex PCR performed of bronchoalveolar lavage fluid increases pathogen identification rate in critically ill patients with pneumonia: a pilot study.

Baudel JL, Tankovic J, Dahoumane R, Carrat F, Galbois A, Ait-Oufella H, Offenstadt G, Guidet B, Maury E.

Ann Intensive Care. 2014 Nov 25;4:35. doi: 10.1186/s13613-014-0035-7. eCollection 2014.

5.

Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study.

Piroth L, Pol S, Miailhes P, Lacombe K, Lopes A, Fillion A, Loustaud-Ratti V, Borsa-Lebas F, Salmon D, Rosenthal E, Carrat F, Cacoub P; The GERMIVIC Study Group.

Liver Int. 2015 Jan 5. doi: 10.1111/liv.12777. [Epub ahead of print]

PMID:
25559645
6.

Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.

Sultanik P, Mallet V, Lagaye S, Casrouge A, Dorival C, Barthe Y, Fontaine H, Hézode C, Mottez E, Bronowicki JP, Carrat F, Theodorou I, Abel L, Gayat E, Fontanet A, Pol S, Albert ML; ANRS CO20-CUPIC.

Liver Int. 2015 Jan 2. doi: 10.1111/liv.12759. [Epub ahead of print]

PMID:
25556540
7.

A sero-epidemiological study of arboviral fevers in Djibouti, horn of Africa.

Andayi F, Charrel RN, Kieffer A, Richet H, Pastorino B, Leparc-Goffart I, Ahmed AA, Carrat F, Flahault A, de Lamballerie X.

PLoS Negl Trop Dis. 2014 Dec 11;8(12):e3299. doi: 10.1371/journal.pntd.0003299. eCollection 2014 Dec.

8.

Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort.

Delabre RM, Lapidus N, Salez N, Mansiaux Y, de Lamballerie X, Carrat F.

Influenza Other Respir Viruses. 2015 Jan;9(1):43-50. doi: 10.1111/irv.12294. Epub 2014 Dec 13.

9.

An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards.

Boursier J, de Ledinghen V, Poynard T, Guéchot J, Carrat F, Leroy V, Wong GL, Friedrich-Rust M, Fraquelli M, Plebani M, Sebastiani G, Myers R, Angulo P, Bertrais S, Wendum D, Bricault I, Calès P; ARDENT group; AFEF.

J Hepatol. 2015 Apr;62(4):807-15. doi: 10.1016/j.jhep.2014.10.042. Epub 2014 Nov 5.

PMID:
25450206
10.

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.

Michot JM, Canioni D, Driss H, Alric L, Cacoub P, Suarez F, Sibon D, Thieblemont C, Dupuis J, Terrier B, Feray C, Tilly H, Pol S, Leblond V, Settegrana C, Rabiega P, Barthe Y, Hendel-Chavez H, Nguyen-Khac F, Merle-Béral H, Berger F, Molina T, Charlotte F, Carrat F, Davi F, Hermine O, Besson C; ANRS HC-13 Lympho-C Study Group.

Am J Hematol. 2015 Mar;90(3):197-203. doi: 10.1002/ajh.23889. Epub 2014 Nov 24.

PMID:
25417909
11.

Causal analysis of H1N1pdm09 influenza infection risk in a household cohort.

Mansiaux Y, Salez N, Lapidus N, Setbon M, Andreoletti L, Leruez-Ville M, Cauchemez S, Gougeon ML, Vély F, Schwarzinger M, Abel L, Delabre RM, Flahault A, de Lamballerie X, Carrat F.

J Epidemiol Community Health. 2015 Mar;69(3):272-7. doi: 10.1136/jech-2014-204678. Epub 2014 Nov 21.

13.

Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.

Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan AB, Abdel-Hamid M, El-Daly M, Gamal ME, El Kassas M, Bedossa P, Carrat F, Fontanet A, Esmat G.

J Viral Hepat. 2015 Mar;22(3):245-53. doi: 10.1111/jvh.12285. Epub 2014 Jul 30.

PMID:
25073725
14.

Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.

Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J.

Antimicrob Agents Chemother. 2014 Sep;58(9):5332-41. doi: 10.1128/AAC.02611-14. Epub 2014 Jun 30.

15.

Characterization of pandemic influenza immune memory signature after vaccination or infection.

Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N, Krivine A, Rozenberg F, Yahia N, Samri A, Rousset D, van der Werf S, Autran B, Combadiere B.

J Clin Invest. 2014 Jul;124(7):3129-36. doi: 10.1172/JCI74565. Epub 2014 Jun 9.

16.

Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.

Miailhes P, Maynard-Muet M, Lebossé F, Carrat F, Bouix C, Lascoux-Combe C, Sogni P, Rey D, Barthe Y, Pol S, Cacoub P, Zoulim F, Piroth L.

J Hepatol. 2014 Oct;61(4):761-9. doi: 10.1016/j.jhep.2014.05.030. Epub 2014 Jun 2.

PMID:
24882048
17.

Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study.

Canini L, Conway JM, Perelson AS, Carrat F.

PLoS Comput Biol. 2014 Apr 17;10(4):e1003568. doi: 10.1371/journal.pcbi.1003568. eCollection 2014 Apr. Erratum in: PLoS Comput Biol. 2014 Jun;10(6):e1003699.

18.

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Hézode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Chazouilleres O, Abergel A, Guyader D, Metivier S, Tran A, Di Martino V, Causse X, Dao T, Lucidarme D, Portal I, Cacoub P, Gournay J, Grando-Lemaire V, Hillon P, Attali P, Fontanges T, Rosa I, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group.

Gastroenterology. 2014 Jul;147(1):132-142.e4. doi: 10.1053/j.gastro.2014.03.051. Epub 2014 Apr 3.

PMID:
24704719
19.

Influenza C virus high seroprevalence rates observed in 3 different population groups.

Salez N, Mélade J, Pascalis H, Aherfi S, Dellagi K, Charrel RN, Carrat F, de Lamballerie X.

J Infect. 2014 Aug;69(2):182-9. doi: 10.1016/j.jinf.2014.03.016. Epub 2014 Apr 4.

PMID:
24704348
20.

Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region.

Bottero J, Boyd A, Lemoine M, Carrat F, Gozlan J, Collignon A, Boo N, Dhotte P, Varsat B, Muller G, Cha O, Valin N, Nau J, Campa P, Silbermann B, Bary M, Girard PM, Lacombe K.

PLoS One. 2014 Mar 24;9(3):e92266. doi: 10.1371/journal.pone.0092266. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk